XML 20 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Profit or Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Continuing operations      
Revenue $ 26,521 $ 18,550 $ 9,654
Cost of revenue 7,711 8,402 4,844
Gross profit 18,810 10,148 4,810
Operating expenses:      
Research and development 3,557 3,824 2,625
Selling and marketing 10,035 11,823 5,742
General and administrative 4,406 6,661 6,839
Impairment of goodwill 6,311 569 700
Contingent consideration income (684)
Total operating expenses 24,309 22,877 15,222
Operating loss (5,499) (12,729) (10,412)
Financial expense (786) (531) (121)
Financial income 196 477 1,063
Financial income (expense), net (590) (54) 942
Loss from continuing operations before income tax (6,089) (12,783) (9,470)
Tax benefit 482 327 945
Loss from continuing operations, net of tax (5,607) (12,456) (8,525)
Profit (loss) from discontinued operations, net of tax 82 (695) (4,600)
Net loss for the year $ (5,525) $ (13,151) $ (13,125)
Basic and diluted profit (loss) per share:      
Continuing operations (in Dollars per share) $ (0.14) $ (0.39) $ (0.31)
Discontinued operations (in Dollars per share) 0 (0.03) (0.17)
Basic loss per share (in Dollars per share) $ (0.14) $ (0.42) $ (0.48)